Cyclic at Biology Products
Cyclic at Biology Technology
Cyclic at Biology Dictionary
Cyclic at Medicine News
Cyclic at Medicine Products
Cyclic AMP, Nephrogenous
Description:ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, maj...
Company:ARUP Laboratories
Cyclic AMP, Plasma
Description:ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, maj...
Company:ARUP Laboratories
Cyclic AMP, Urine
Description:ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, maj...
Company:ARUP Laboratories
Cyclic Citrullinated Peptide Antibody, IgG
Description:ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, maj...
Company:ARUP Laboratories
Tricyclic Antidepressant Identification Quantitative, Serum
Description:ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, maj...
Company:ARUP Laboratories
More>>
Cyclic at Medicine Technology
Pharmacyclics Announces Interim Results From Two Ongoing Phase 2
Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat
Recurrent Non-Small Cell Lung Cancer
WAILEA, Hawaii and SUNNYVALE, Calif., June 27, 2007/PRNewswire-FirstCall/ -- Pharma
cyclics, Inc. today announcedpreliminary results from two open-label, multi-center Phase 2clinical trials supporting the potential use of Xcytrin(R)(motexafin gadolinium) Injection, the company's lead productcandidate, in combination with Alimta(R) (pemetrexed) and incombination with Taxotere(R) (docetaxel...
Pharmacyclics Announces Promising Results From Phase 2 Clinical
Trial of Xcytrin in Recurrent, Metastatic Non-Small Cell Lung
Cancer
- Data Support Rationale for Comprehensive Ongoing Phase 2 Programas Combination Agent with Standard Chemotherapies and Pivotal LungCancer Trial Scheduled to Begin Early Next Year - CHICAGO and SUNNYVALE, Calif. June 01, 2007/PRNewswire-FirstCall/ -- Pharma
cyclics, Inc. today announcedpromising preliminary results from an open-label Phase 2 clinicaltrial of Xcytrin(R) (motexafin gadoliniu...
Pharmacyclics Announces Presentations and Published Abstracts on
Xcytrin at The 2007 American Society of Clinical Oncology Annual
Meeting
SUNNYVALE, Calif., May 23, 2007 /PRNewswire-FirstCall/ --Pharma
cyclics, Inc. announced today multiple presentations and apublished abstract regarding Xcytrin(R) (motexafin gadolinium)Injection, including an oral presentation of Phase 3 SMART (Studyof Neurologic Progression with Motexafin Gadolinium And RadiationTherapy) trial data. The presentations and publications are part ofthe procee...
Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC
Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with
Bruton's Tyrosine Kinase Inhibitors
SUNNYVALE, Calif. and LOS ANGELES, April 18, 2007/PRNewswire-FirstCall/ -- Pharma
cyclics, Inc. today announced datafrom two preclinical studies, one identifying a functionalbiomarker for its novel histone deacetylase (HDAC) inhibitor andanother demonstrating preclinical anti-tumor activity with itsBruton's tyrosine kinase (BTK) inhibitor compounds. The data werepresented at the American...
Pharmacyclics Announces Presentations on Its Novel and Selective
HDAC and Bruton's Tyrosine Kinase Inhibitor Compounds
SUNNYVALE, Calif., April 11, 2007 /PRNewswire-FirstCall/ --Pharma
cyclics, Inc. announced today multiple presentationsregarding its novel histone deacetylase (HDAC) inhibitor andBruton's tyrosine kinase inhibitor compounds. The presentationswill take place at the American Association for Cancer Research(AACR) 2007 Annual Meeting being held April 14-18, 2007, at the LosAngeles Convention C...